Marine Natural Products as Anti-Cancer Agents

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (30 May 2008) | Viewed by 12299

Special Issue Editor


E-Mail Website
Guest Editor
Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, MS 38677, USA
Interests: marine biotechnology; pharmacognosy; natural products; semisynthesis; medicinal chemistry

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

101 KiB  
Article
Large-Scale Biotechnological Production of the Antileukemic Marine Natural Product Sorbicillactone A
by Gerhard Bringmann, Tobias A. M. Gulder, Gerhard Lang, Stefanie Schmitt, Rüdiger Stöhr, Jutta Wiese, Kerstin Nagel and Johannes F. Imhoff
Mar. Drugs 2007, 5(2), 23-30; https://doi.org/10.3390/md502023 - 25 Jun 2007
Cited by 52 | Viewed by 11927
Abstract
In the search for novel bioactive compounds from sponge-derived microorganisms, we have recently identified two structurally and biosynthetically unprecedented fungal metabolites, the novel-type alkaloids sorbicillactone A and sorbicillactone B. Sorbicillactone A is active against leukemia cells without showing notable cytotoxicity. Therefore, we have [...] Read more.
In the search for novel bioactive compounds from sponge-derived microorganisms, we have recently identified two structurally and biosynthetically unprecedented fungal metabolites, the novel-type alkaloids sorbicillactone A and sorbicillactone B. Sorbicillactone A is active against leukemia cells without showing notable cytotoxicity. Therefore, we have developed an efficient process for its biotechnological production and isolation on a large scale supplying sufficient material for the ongoing preclinical investigations and structure-activity relationship (SAR) studies. Full article
(This article belongs to the Special Issue Marine Natural Products as Anti-Cancer Agents)
Show Figures

Figure 1

Back to TopTop